Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$46.9M |
| 2 |
Cloudflare
NET
|
+$38.2M |
| 3 |
10x Genomics
TXG
|
+$33.7M |
| 4 |
Teladoc Health
TDOC
|
+$31.9M |
| 5 |
Pinduoduo
PDD
|
+$31.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$349M |
| 2 |
Microsoft
MSFT
|
+$191M |
| 3 |
Amazon
AMZN
|
+$136M |
| 4 |
Meta Platforms (Facebook)
META
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$73.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Healthcare | 14.37% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Communication Services | 10.64% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Deluxe
DLX
$1.09B
| $2.77M | ﹤0.01% |
94,800
| – | – |
|
|
SILV
1727
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $2.77M | ﹤0.01% |
248,200
+1,400
| +0.6% | +$13.2K |
|
|
KRTX
1728
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.75M | ﹤0.01% |
27,100
+400
| +1% | +$37.1K |
|
|
BWIN
1729
Baldwin Insurance Group
BWIN
$3B
| $2.75M | ﹤0.01% |
+91,700
| New | +$2.65M |
|
1730
NETGEAR
NTGR
$658M
| $2.75M | ﹤0.01% |
67,600
+600
| +0.9% | +$20.4K |
|
1731
Castle Biosciences
CSTL
$960M
| $2.75M | ﹤0.01% |
40,900
+14,800
| +57% | +$802K |
|
1732
AAR Corp
AIR
$5.96B
| $2.74M | ﹤0.01% |
75,600
| – | – |
|
|
LGF.B
1733
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.73M | ﹤0.01% |
262,994
| – | – |
|
1734
uniQure
QURE
$3.26B
| $2.72M | ﹤0.01% |
75,300
| – | – |
|
|
PGTI
1735
DELISTED
PGT, Inc.
PGTI
| $2.72M | ﹤0.01% |
133,600
| – | – |
|
1736
ADT
ADT
$5.34B
| $2.71M | ﹤0.01% |
344,700
| – | – |
|
1737
Macerich
MAC
$6.99B
| $2.7M | ﹤0.01% |
253,415
+12,800
| +5% | +$116K |
|
1738
ePlus
PLUS
$2.32B
| $2.69M | ﹤0.01% |
61,256
| – | – |
|
1739
Universal Corp
UVV
$1.13B
| $2.69M | ﹤0.01% |
55,400
| – | – |
|
1740
The Greenbrier Companies
GBX
$1.41B
| $2.69M | ﹤0.01% |
74,000
| – | – |
|
1741
Vericel Corp
VCEL
$2.29B
| $2.69M | ﹤0.01% |
87,000
-4,700
| -5% | -$112K |
|
|
RAVN
1742
DELISTED
Raven Industries Inc
RAVN
| $2.69M | ﹤0.01% |
81,200
| – | – |
|
1743
Delek US
DK
$4.12B
| $2.68M | ﹤0.01% |
166,619
| – | – |
|
|
ALEX
1744
DELISTED
Alexander & Baldwin
ALEX
| $2.67M | ﹤0.01% |
155,720
| – | – |
|
1745
Core Laboratories
CLB
$571M
| $2.67M | ﹤0.01% |
100,800
| – | – |
|
1746
Astec Industries
ASTE
$994M
| $2.67M | ﹤0.01% |
46,100
| – | – |
|
1747
Travere Therapeutics
TVTX
$5.86B
| $2.67M | ﹤0.01% |
97,800
+2,100
| +2% | +$49K |
|
|
SVM
1748
Silvercorp Metals
SVM
$2.68B
| $2.67M | ﹤0.01% |
398,400
+2,200
| +0.6% | +$15.1K |
|
|
EVRI
1749
DELISTED
Everi Holdings
EVRI
| $2.66M | ﹤0.01% |
192,800
| – | – |
|
1750
MacroGenics
MGNX
$259M
| $2.66M | ﹤0.01% |
116,200
+10,400
| +10% | +$239K |
|
Similar funds
Swiss National Bank's Q4 2020 Portfolio in Review
As of Q4 2020, Swiss National Bank held 2,555 positions worth $141B, up 10% from $128B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q4 2020 filing shows 125 new, 501 increased, 893 reduced and 65 closed positions. Its largest new stake was Cloudflare: 582,300 shares worth $44.2M. The largest sale was Apple, an estimated $349M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2020 buy was Cloudflare: 582,300 shares worth $44.2M.
- Swiss National Bank added most to Viatris in Q4 2020, an estimated $46.9M increase.
- Swiss National Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $349M.
- Swiss National Bank fully exited Immunomedics Inc in Q4 2020, selling an estimated $37.8M.
- Swiss National Bank's ten largest holdings make up 24% of its $141B portfolio in Q4 2020.
- Swiss National Bank opened 125 new positions and closed 65 in Q4 2020.
- Swiss National Bank's portfolio value rose 10% quarter-over-quarter to $141B.
Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.